A number of Biotech e.g. MSB over 1.2bln Market Cap and not FDA on horizon...
next 2-3 weeks - climb to 40c...45c - starts to sink in..
Post FDA ..expecting a good run 60-100% - 70 to 80c level...
Biggest gainers will be 12months after FDA to $2 or $3 based on Sales trajectory...
Basically : 3% of 3.7mln and 1% of 6.3mln = 174 000 patients - very likely to hit in first 12 -18months...
174 000 patients by 6 refills by usd 500net Revenue ( after sharing with distributors/ pharma / dermatologists) = Solid usd 520mln Net Revenue
15x of that is usd 7.8bln or usd 5.2 per share price...
People whi disagree with Fast rump up - can look at trajectory in Japan and to sleep quite divide my number by 2and still get usd 2.6 per share...
Remember refills and Japan still has 70% new patents every year..
BOT - Anything but charting, page-8468
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.5¢ | 37.5¢ | $1.701M | 4.493M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 523247 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 146093 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |